CNR1 and female reproductive organ cancer: Perturbators of CB1 and FAAH1-linked pathways in gynecological cancers are mainly studied using endo/phytocannabinoid/cannabidiol ligands like ∆9-THC, WIN55, 212-2, anandamide and (+) methAEA and also HU-210 in recent years [40,41].